Abstract
Background Eye tracking (ET) is emerging as a promising early and objective screening method for autism spectrum disorders (ASD), but it requires more reliable metrics with enhanced sensitivity and specificity for clinical use.
Methods This study introduces a suite of novel ET metrics: Area of Interest (AOI) Switch Counts (ASC), Favorable AOI Shifts (FAS) along self-determined pathways, and AOI Vacancy Counts (AVC). These metrics were applied to toddlers and preschoolers diagnosed with ASD. The correlation between these new ET metrics and Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) scores was assessed using linear regression. Sensitivity and specificity of the cut-off scores were also evaluated to predict diagnosis.
Results Our findings indicate significantly lower FAS and ASC and higher AVC (P<0.05) in children with ASD compared to their non-ASD counterparts within this high-risk cohort. There were no significant differences in total fixation time or pupil size (p > 0.05). Additionally, FAS was negatively correlated with ADOS-2 total scores and the social affect (SA) subscale (p < 0.05). Among these new ET metrics, AVC yielded the best sensitivity (88-100%) and specificity (80-88%) with a cut-off score of 0.305-0.306, followed by FAS and ASC for distinguishing ASD from non-ASD for diagnosis.
Conclusions This study confirms the utility of innovative ET metrics—FAS, AVC, and ASC, which exhibit markedly improved sensitivity and specificity, enhancing ASD screening and diagnostic processes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Massachusetts General Hospital, grant numbers #230361 and #233263.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board of Massachusetts General Hospital gave ethical approval for this work. (2017P001667, 13 July 2018; 2020P004102; January 7, 2021)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
List of Abbreviations
- ET
- Eye-tracking
- ASD
- Autism Spectrum Disorder
- AOI
- Area of Interest
- ASC
- AOI Switch Counts
- FAS
- Favored AOI Shifts
- UAS
- Unfavored AOI Shifts
- AVC
- AOI Vacancy Counts
- ADOS-2
- Autism Diagnostic Observation Schedule, Second Edition
- DSM-5
- Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
- TFT
- Total Fixation Count
- TGC
- Total Gaze Count
- M-CHAT
- Modified Checklist for Autism in Toddlers
- SA
- Social Affect
- RRB
- Restrictive and Repetitive Behaviors
- CSS
- Calibrated Severity Score
- ToM
- Theory of Mind
- ADHD
- Attention Deficit and Hyperactive Disorder
